Skip to main content
Equibles

Swiss National Bank

Bank

Position in ZYME — Zymeworks Inc.

CIK 1582202 ZURICH, V8
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,939,588
+$81,620 QoQ
Shares Held
74,200
0.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 202 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. ZYME ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in ZYME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,939,588 74,200
2026-03-31 $1,857,968 74,200
2025-12-31 $1,953,686 74,200
2025-09-30 $1,248,548 73,100
2025-06-30 $917,405 73,100
2025-03-31 $953,991 80,100
2024-12-31 $1,320,528 90,200
2024-09-30 $1,132,010 90,200
2024-06-30 $767,602 90,200
2024-03-31 $873,160 83,000
2023-12-31 $764,704 73,600
2023-09-30 $491,984 77,600
2023-06-30 $603,072 69,800
2023-03-31 $1,167,968 129,200